The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients

Ingeborg J. H. Vriens(Maastricht University), Vivianne C. G. Tjan‐Heijnen(Maastricht University Medical Centre), Irene E.G. van Hellemond(Maastricht University), Adri C. Voogd(Maastricht University Medical Centre), Joyce H.E. Roijen(Maastricht University), Maaike de Boer(Maastricht University), Ron J T van Golde(Maastricht University), Maureen J.B. Aarts(Maastricht University Medical Centre), Ashley J.R. De Bie(Radboud University Nijmegen)
Oncotarget
January 5, 2017
10.18632/oncotarget.14532
Cited by 26

Related Papers

Pervasive chromosomal instability and karyotype order in tumour evolution
|Nature|2020|401
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial
|The Lancet Oncology|2017|158
Local recurrence after breast conservation therapy for early stage breast carcinoma
|Cancer|1999|154
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
|Nature Medicine|2021|115
Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women
|JNCI Journal of the National Cancer Institute|2016|85